Dental Implant FailedPhase 4NCT05838365
Immediate Versus Delayed Loading of Single Posterior Zirconia Implants
A Phase 4 study testing Zirconia implant in people with Dental Implant Failed and Peri-implant Mucositis, run by University of Milan at 1 site in Italy.
Trial summary
The main aim of the present study is to investigate implant success rate after 5 years of function of immediate (Test group; within 7 days of implant placement) versus delayed (Control group; 8 weeks after implant placement) loading of two-pieces zirconia implant, placed in pristine bone without bone regeneration. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Dental Implant Failed, Peri-implant Mucositis, Peri-Implantitis
- What is being tested?
- Zirconia implant
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 220 participants
- Where
- 1 siteItaly
- Study dates
- 1 Dec 2022to 1 Jun 2029
- Phase
- Phase 4
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Sistemically healthy patients
- partial edentulism
- premolar position
- molar position
- Bone width and height at least 6 and 10mm, respectively.
- Keratinized tissue, at least 1 mm at implant site
- Full understanding of the proposed surgical treatments and the protocol schedule
- Full comprehension and availability to sign the informed consent form
Who cannot join
- Heavy smokers (>10 cigarettes a day)
- Serious kidney or liver diseases
- Uncontrolled diabetes
- Bisphosphonates intake
- History of radiotherapy of the head and neck
- Current antiblastic chemotherapy
Show all 13Show fewer
- Congenital (primary) or acquired (secondary) immunodeficiency
- Pregnant women
- Connective tissue disorders
- Local exclusion criteria:
- untreated stage III/IV periodontitis
- Autoimmune diseases
- oral parafunctions
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
San Paolo Hospital
Milan
Eugenio Romeo, Full Professor, +39 0250319039, eugenio.romeo@unimi.it
About this study
Official title: Immediate Versus Delayed Loading of Single Posterior Zirconia Implants: A Multicenter Randomized Controlled Clinical Trial
The main aim of the present study is to investigate implant success rate after 5 years of function of immediate (Test group; within 7 days of implant placement) versus delayed (Control group; 8 weeks after implant placement) loading of two-pieces zirconia implant, placed in pristine bone without bone regeneration. Implant success rate will be defined according to Buser's criteria. Secondary endpoints: Marginal bone level (MBL) evaluation by means of standardized radiographs; Clinical evaluation of biological (e.g. Plaque Index, PI; Probing Pocket Depth, PPD, Bleeding on Probing, BOP; suppuration upon probing/palpation) and prosthetic/technical complications; Clinical evaluation of soft tissue width, keratinized tissue, marginal and interproximal soft tissue recession; Patient reported outcome measures (PROMs) by questionnaire administration:
- Being tested
- Zirconia implant
- Medical subject headings
- Peri-Implantitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Zirconia implantDevice
(Test group; within 7 days of implant placement) versus delayed (Control group; 8 weeks after implant placement)
| Study group | Role | What they receive |
|---|---|---|
| Immediate loading zirconia implant | Experimental | Loading of zirconia dental implant within 7 days after implant placement Receives: Device: Zirconia implant |
| Delayed loading zirconia implant | Active comparator | Loading of zirconia dental implants after at least 2 months of healing Receives: Device: Zirconia implant |
What is being measured
The primary outcome is the main question the study is designed to answer.
Implant success rate according to Buser's criteria
presence of subjective complaints related to the area of treatment; recurrent infections in the peri-implant region accompanied by suppuration; mobility of the implant fixture
Measured: 5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2023
- Study start1 Dec 2022
- Primary completion1 Jun 2024 (estimated)
- Study completion1 Jun 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dental Implant FailedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 220 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Milan
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Antonino Palazzolo, University of Milan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05838365
- Sponsor's protocol ID
- 74/22
- Status last verified
- Apr 2023
- First submitted
- 5 Mar 2023
- Last updated
- 1 May 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Primary and secondary endpoints; indicators of central tendency; evidence summary; tables; figures.